Intact circulating tumour cells (CTCs) and cell-free circulating tumour DNA are two types of cancer-derived materials found in blood that may be thoroughly molecularly analysed (cfDNA; also referred to as circulating tumour DNA, or ctDNA). Passive release of cfDNA into the bloodstream can occur when the tumor's volume exceeds the phagocytes' ability to clear away and remove apoptotic and necrotic pieces. Doctors can examine DNA that tumours generally release into the bloodstream using the blood taken from the patient's arm. The proportion of cfDNA released into the circulation can range from 0.01% to 90% of all DNA found in plasma, depending on the tumour size and vascularity. In order to do tumour genetic profiling without obtaining tumour tissue, Liquid Biopsy offer a noninvasive method.
